Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Jelena Martinovic

PharmaDrug Posts Positive Results For DMT-Analogue Program To Treat Glaucoma

Psychedelics and cannabis-focused pharmaceutical company PharmaDrug Inc. (CSE:PHRX) (OTCQB:LMLLF) has completed a head-to-head potency comparator study of its two undisclosed DMT-analogue candidates for the treatment of primary open angle glaucoma.

What Happened?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.